Evaluating the Effectiveness of the Acute Respiratory Infection Smart Form
To evaluate the effectiveness of the Acute Respiratory Infection Smart...
Brief Summary
Official Title: “Evaluating Smart Forms and Quality Dashboards in an EHR: Effectiveness of the Acute Respiratory Infection Smart Form”
To evaluate the effectiveness of the Acute Respiratory Infection Smart Form
- Study Type: Interventional
- Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
- Study Primary Completion Date: May 2006
Detailed Clinical Trial Description
Specific Aim 1: To design and implement an integrated documentation-based clinical decision support and physician feedback system, provided in an electronic health record (EHR), to improve the management of patients with acute medical conditions.
Hypothesis 1: A documentation-based clinical decision support tool (CDSS) "smart form" physician feedback system, can be designed and implemented to facilitate documentation and physician order-entry, provide individualized, evidence-based recommendations for the management of patients acute respiratory infections (ARIs), and are usable by primary care physicians.
Specific Aim 2: To determine the effectiveness of documentation-based CDSS and physician feedback on documentation and the clinical management of patients respiratory tract infections.
Hypothesis 2A: A documentation-based CDSS "smart form" will increase the documentation of important clinical data in patients with ARI when compared to usual practice.
Hypothesis 2B: A documentation-based CDSS "smart form" will increase adherence with guidelines for the management of patients with ARI when compared to usual practice.
Intervention(s) in this Clinical Trial
- Behavioral: Smart Form
- Computer Decision Support System
Arms, Groups and Cohorts in this Clinical Trial
- Other: 1
- Intervention
- No Intervention: 2
- Control
Outcome Measures for this Clinical Trial
Primary Measures
- Antibiotic prescribing rates
- Time Frame: 9 months
Safety Issue?: No
- Time Frame: 9 months
Secondary Measures
- Appropriateness of antibiotic prescribing, re-visit rates, antibiotic costs, use of antibiotics, all-cause antibiotic use, quality of documentation
- Time Frame: 9 months
Safety Issue?: No
- Time Frame: 9 months
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Acute Respiratory Infection visit
Exclusion Criteria:
- Any patients who are not part of a panel of a participating physician
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Agency for Healthcare Research and Quality (AHRQ) U.S. Fed
Overall Clinical Trial Officials and Contacts
Blackford Middleton, MD, MPH, MSc Principal Investigator Partners Healthcare Systems Inc
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00235040
Study ID Number: R01HS015169-1
ClinicalTrials.gov Identifier: NCT00235040
Health Authority: United States: Federal Government
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00235040
